Mao CQ - Search Results

1

Triple negative breast cancer therapy with CDK1 siRNA delivered by cationic lipid assisted PEG-PLA nanoparticles.

Liu Y, Zhu YH, Mao CQ, Dou S, Shen S, Tan ZB, Wang J. Liu Y, et al. Among authors: mao cq. J Control Release. 2014 Oct 28;192:114-21. doi: 10.1016/j.jconrel.2014.07.001. Epub 2014 Jul 10. J Control Release. 2014. PMID: 25016158

2

Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy.

Yang XZ, Dou S, Sun TM, Mao CQ, Wang HX, Wang J. Yang XZ, et al. Among authors: mao cq. J Control Release. 2011 Dec 10;156(2):203-11. doi: 10.1016/j.jconrel.2011.07.035. Epub 2011 Aug 1. J Control Release. 2011. PMID: 21839126

3

Sheddable ternary nanoparticles for tumor acidity-targeted siRNA delivery.

Yang XZ, Du JZ, Dou S, Mao CQ, Long HY, Wang J. Yang XZ, et al. Among authors: mao cq. ACS Nano. 2012 Jan 24;6(1):771-81. doi: 10.1021/nn204240b. Epub 2011 Dec 9. ACS Nano. 2012. PMID: 22136582

4

Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA.

Yang XZ, Dou S, Wang YC, Long HY, Xiong MH, Mao CQ, Yao YD, Wang J. Yang XZ, et al. Among authors: mao cq. ACS Nano. 2012 Jun 26;6(6):4955-65. doi: 10.1021/nn300500u. Epub 2012 Jun 5. ACS Nano. 2012. PMID: 22646867

5

Anti-Her2 single-chain antibody mediated DNMTs-siRNA delivery for targeted breast cancer therapy.

Dou S, Yao YD, Yang XZ, Sun TM, Mao CQ, Song EW, Wang J. Dou S, et al. Among authors: mao cq. J Control Release. 2012 Aug 10;161(3):875-83. doi: 10.1016/j.jconrel.2012.05.015. Epub 2012 May 14. J Control Release. 2012. PMID: 22762887

6

Cancer stem cell therapy using doxorubicin conjugated to gold nanoparticles via hydrazone bonds.

Sun TM, Wang YC, Wang F, Du JZ, Mao CQ, Sun CY, Tang RZ, Liu Y, Zhu J, Zhu YH, Yang XZ, Wang J. Sun TM, et al. Among authors: mao cq. Biomaterials. 2014 Jan;35(2):836-45. doi: 10.1016/j.biomaterials.2013.10.011. Epub 2013 Oct 18. Biomaterials. 2014. PMID: 24144908

7

Synthetic lethal therapy for KRAS mutant non-small-cell lung carcinoma with nanoparticle-mediated CDK4 siRNA delivery.

Mao CQ, Xiong MH, Liu Y, Shen S, Du XJ, Yang XZ, Dou S, Zhang PZ, Wang J. Mao CQ, et al. Mol Ther. 2014 May;22(5):964-73. doi: 10.1038/mt.2014.18. Epub 2014 Feb 5. Mol Ther. 2014. PMID: 24496383 Free PMC article.

8

Matrix metalloproteinase 2-responsive micelle for siRNA delivery.

Wang HX, Yang XZ, Sun CY, Mao CQ, Zhu YH, Wang J. Wang HX, et al. Among authors: mao cq. Biomaterials. 2014 Aug;35(26):7622-34. doi: 10.1016/j.biomaterials.2014.05.050. Epub 2014 Jun 11. Biomaterials. 2014. PMID: 24929619

9

Simultaneous delivery of siRNA and paclitaxel via a "two-in-one" micelleplex promotes synergistic tumor suppression.

Sun TM, Du JZ, Yao YD, Mao CQ, Dou S, Huang SY, Zhang PZ, Leong KW, Song EW, Wang J. Sun TM, et al. Among authors: mao cq. ACS Nano. 2011 Feb 22;5(2):1483-94. doi: 10.1021/nn103349h. Epub 2011 Jan 4. ACS Nano. 2011. PMID: 21204585

10

A biodegradable amphiphilic and cationic triblock copolymer for the delivery of siRNA targeting the acid ceramidase gene for cancer therapy.

Mao CQ, Du JZ, Sun TM, Yao YD, Zhang PZ, Song EW, Wang J. Mao CQ, et al. Biomaterials. 2011 Apr;32(11):3124-33. doi: 10.1016/j.biomaterials.2011.01.006. Epub 2011 Jan 28. Biomaterials. 2011. PMID: 21277018

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters